Atlas Trials

Gardasil Vaccination in Post Stem Cell Transplant Patients

Clinical trial NCT01092195 · COMPLETED

Trial details

NCT number
NCT01092195
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gardasil VaccineStem Cell TransplantImmunogenicity
Start date
2010-06-02
Primary completion
2016-07-19
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.